{"entity":{"type":"insider","cik":"0001834681","url":"/insider/0001834681","json_url":"/insider/0001834681.json","name":"Pamir Ozan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2021-12-13","last":"2025-11-17","span_basis":"filed_date"},"name_variants":[{"name":"Pamir Ozan","source":"filing","n_filings":4,"first_seen":"2021-12-13","last_seen":"2025-11-17"}],"transactions":[{"id":4155795,"accession":"0001834681-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001834681-25-000005","line_url":"/filing/0001834681-25-000005","is_derivative":false,"issuer_cik":"0001386570","issuer_name":"Niagen Bioscience, Inc.","issuer_ticker":"NAGE","issuer_name_source":null,"issuer_url":"/issuer/0001386570","owner_cik":"0001834681","owner_name":"Pamir Ozan","owner_display_name":"Pamir Ozan","owner_url":"/insider/0001834681","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6685.405,"shares_display":"6,685.40","price_per_share":6.823285316297218,"price_display":"6.82","price_state":"stated","total_value":45616.42577,"total_display":"45,616.43","total_whole":"45,616","shares_owned_after":7372.159,"shares_owned_after_display":"7,372.16","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-14","filed_date":"2025-11-17","scope":"insider","n_lines":2},{"id":3269375,"accession":"0001628280-24-049079","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-049079","line_url":"/filing/0001628280-24-049079#line-1","is_derivative":false,"issuer_cik":"0001386570","issuer_name":"ChromaDex Corp.","issuer_ticker":"CDXC","issuer_name_source":null,"issuer_url":"/issuer/0001386570","owner_cik":"0001834681","owner_name":"Pamir Ozan","owner_display_name":"Pamir Ozan","owner_url":"/insider/0001834681","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2907.197,"shares_display":"2,907.20","price_per_share":7.36,"price_display":"7.36","price_state":"stated","total_value":21396.96992,"total_display":"21,396.97","total_whole":"21,397","shares_owned_after":2907.197,"shares_owned_after_display":"2,907.20","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-22","filed_date":"2024-11-25","scope":"insider"},{"id":7872515,"accession":"0001213900-23-041328","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-041328","line_url":"/filing/0001213900-23-041328#line-1","is_derivative":false,"issuer_cik":"0001690080","issuer_name":"180 Life Sciences Corp.","issuer_ticker":"ATNF","issuer_name_source":null,"issuer_url":"/issuer/0001690080","owner_cik":"0001834681","owner_name":"Pamir Ozan","owner_display_name":"Pamir Ozan","owner_url":"/insider/0001834681","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5162.077,"shares_display":"5,162.08","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":5213.69777,"total_display":"5,213.70","total_whole":"5,214","shares_owned_after":8983.077,"shares_owned_after_display":"8,983.08","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-19","scope":"insider"},{"id":5407527,"accession":"0001213900-21-064876","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-064876","line_url":"/filing/0001213900-21-064876#line-1","is_derivative":false,"issuer_cik":"0001690080","issuer_name":"180 Life Sciences Corp.","issuer_ticker":"ATNF","issuer_name_source":null,"issuer_url":"/issuer/0001690080","owner_cik":"0001834681","owner_name":"Pamir Ozan","owner_display_name":"Pamir Ozan","owner_url":"/insider/0001834681","role":"Officer (Interim CFO)","role_mark":"O","role_mark_label":"Officer (Interim CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3800.0,"shares_display":"3,800","price_per_share":3.87,"price_display":"3.87","price_state":"stated","total_value":14706.0,"total_display":"14,706.00","total_whole":"14,706","shares_owned_after":76408.0,"shares_owned_after_display":"76,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001386570","name":"Niagen Bioscience, Inc.","url":"/issuer/0001386570","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2024-11-25","last_seen":"2025-11-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001690080","name":"180 Life Sciences Corp.","url":"/issuer/0001690080","role":"Officer (CFO)","n_filings":2,"first_seen":"2021-12-13","last_seen":"2023-05-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001834681","retrieved_at":"2026-08-26T14:50:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}